Inter-laboratory testing as a strategy for external quality assessment for qualitative detection of SARS-CoV-2 by real-time RT-PCR testing in India

To implement the strategy of test, track and treat to tackle the ongoing COVID-19 pandemic, the number of real-time RT-PCR–based testing laboratories was increased for diagnosis of SARS-CoV-2 in the country. To ensure reliability of the laboratory results, the Indian Council of Medical Research init...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Harmanmeet, Mukhopadhyay, Labanya, Aggarwal, Neeraj, Gupta, Nivedita, Narayan, Jitendra, Vijay, Neetu, Gupta, Swati, Rana, Salaj, Kaur, Jasmine, Kumar, Vinit, Singh, Harpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552377/
https://www.ncbi.nlm.nih.gov/pubmed/35859435
http://dx.doi.org/10.4103/ijmr.ijmr_2433_21
Descripción
Sumario:To implement the strategy of test, track and treat to tackle the ongoing COVID-19 pandemic, the number of real-time RT-PCR–based testing laboratories was increased for diagnosis of SARS-CoV-2 in the country. To ensure reliability of the laboratory results, the Indian Council of Medical Research initiated external quality assessment (EQA) by deploying inter-laboratory quality control (ILQC) activity for these laboratories by nominating 34 quality control (QC) laboratories. This report presents the results of this activity for a period of September 2020 till November 2020. A total of 597 laboratories participated in this activity and 86 per cent of these scored ≥90 per cent concordance with QC laboratories. This ILQC activity showcased India’s preparedness in quality diagnosis of SARS-CoV-2.

Ejemplares similares